Microbix Biosystems Inc. (MBX.TO)
| Previous Close | 0.3350 |
| Open | 0.3300 |
| Bid | 0.3200 x 0 |
| Ask | 0.3250 x 0 |
| Day's Range | 0.3150 - 0.3350 |
| 52 Week Range | 0.2300 - 0.4700 |
| Volume | |
| Avg. Volume | 72,234 |
| Market Cap | 44.661M |
| Beta (5Y Monthly) | 0.23 |
| PE Ratio (TTM) | 10.83 |
| EPS (TTM) | 0.0300 |
| Earnings Date | May 09, 2024 - May 13, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Sept 02, 1999 |
| 1y Target Est | 0.80 |
- Baystreet
Stocks in play: Microbix Biosystems Inc.
Is presenting results of its use of Microbix Quality Assessment Products for accreditation of clinical ...
GlobeNewswireMicrobix Collaborator Introduces New Lab Accreditation Program
Microbix Product Supporting Testing for Drug-Resistant Sexually-Transmitted InfectionMISSISSAUGA, Ontario, April 25, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that Labquality Ltd., a collaborator and customer, is presenting results of its use of Microbix Quality Assessment Products (“QAPs™”) for accreditation of clinical labs for conducting molecular (“MDx”) tests for antimicrobial-resis
- GlobeNewswire
Microbix Presenting at the 2024 Bloom Burton Conference
MISSISSAUGA, Ontario, April 11, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces it will be attending and presenting at the Bloom Burton & Co. Healthcare Investor Conference (the “Conference”) taking place at the Metro Toronto Convention Center, North Building, on April 16 and 17, 2024. The Conference provides an opportunity to connect with Canadian, U.S., and international investors who are in
